Molecular diagnosis of Toxoplasma gondii infection in cerebrospinal fluid from AIDS patients

doi:10.1186/1743-8454-6-2

Cerebrospinal Fluid Research

Volume 6

Viewing options:

Abstract
Full text
PDF (316KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Alfonso Y
Fraga J
Fonseca C
Jiménez N
Pinillos T
Dorta-Contreras AJ
Cox R
Capó V
Pomier O
Bandera F
Ginorio D

on PubMed

Alfonso Y
Fraga J
Fonseca C
Jiménez N
Pinillos T
Dorta-Contreras AJ
Cox R
Capó V
Pomier O
Bandera F
Ginorio D
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research

Molecular diagnosis of Toxoplasma gondii infection in cerebrospinal fluid from AIDS patients

Yenisey Alfonso¹ , Jorge Fraga¹ , Carlos Fonseca² , Narciso Jiménez² , Taimy Pinillos² , Alberto J Dorta-Contreras³ , Raymundo Cox¹ , Virginia Capó² , Olga Pomier² , Francisco Bandera² and Dora Ginorio¹

¹Parasitology Department, Institute of Tropical Medicine 'Pedro Kourí', PO Box 601, Marianao 13, Ciudad de La Habana, Cuba

²Health Care Division, Institute of Tropical Medicine 'Pedro Kourí', PO Box 601, Marianao 13, Ciudad de La Habana, Cuba

³Central Laboratory of Cerebrospinal Fluid (LABCEL), PO Box 10049, Ciudad de la Habana, Cuba

author email corresponding author email

Cerebrospinal Fluid Research 2009, 6:2doi:10.1186/1743-8454-6-2


Published:	6 March 2009

Abstract

Background

Toxoplasmic encephalitis (TE) is one of the most common opportunistic infections in immunocompromised patients. In Cuba, despite the highly active antiretroviral therapy, TE is still the most important cause of cerebral mass lesions in patients infected with the human immunodeficiency virus (HIV). The detection of Toxoplasma gondii by PCR may facilitate the diagnosis and follow-up of TE in acquired immunodeficiency syndrome (AIDS) patients by direct identification of parasite DNA in clinical samples. The aim of the present study was to evaluate a rapid PCR method using the B1 gene to detect T. gondii in cerebrospinal fluid (CSF) samples from patients with suspected TE.

Methods

CSF samples from AIDS and HIV-negative patients were analyzed. Patients were divided into two groups according to the Centre for Disease Control and Prevention (CDC) criteria for AIDS-related TE: AIDS patients with suspected neurotoxoplasmosis and AIDS and HIV-negative patients with other confirmed neurological diseases but no suspicions of TE. Predictive values, diagnostic accuracy, sensitivity and specificity of the PCR B1 method were calculated.

Results

The results obtained from 190 patients showed that this assay has a good sensitivity and specificity (83.3% and 95.7%, respectively) for the diagnosis of TE in AIDS patients.

Conclusion

PCR using the B1 gene and B22/B23 set of primers is a single, rapid and reliable method that may be valuable for discrimination between toxoplasmosis and other central nervous system (CNS) diseases.